Waverly Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.5M Sell
29,742
-1,070
-3% -$149K 0.03% 504
2025
Q4
$5.05M Buy
30,812
+375
+1% +$58.7K 0.04% 374
2025
Q3
$4.07M Buy
30,437
+10,105
+50% +$1.23M 0.04% 356
2025
Q2
$2.53M Sell
20,332
-100
-0.5% -$12.7K 0.03% 448
2025
Q1
$2.6M Buy
+20,432
New +$3.15M 0.03% 426

Other funds holding RGEN

Waverly Advisors's RGEN Position: Q1 2026 in Review

Waverly Advisors reduced its Repligen (RGEN) stake by 3.5% in Q1 2026, selling an estimated $149K and leaving 29,742 shares worth $3.5M. The position accounts for 0.03% of the portfolio, ranked #504.

Waverly Advisors first reported a position in RGEN in Q1 2025 and has held it in 5 quarters since. The position peaked at $5.05M in Q4 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Waverly Advisors held 29,742 shares of Repligen worth $3.5M as of Q1 2026.
  • Waverly Advisors sold 1,070 Repligen shares in Q1 2026, an estimated $149K.
  • Repligen made up 0.03% of Waverly Advisors's portfolio in Q1 2026, its #504 holding.
  • Waverly Advisors first reported a position in Repligen in Q1 2025 and has held it in 5 quarters since.
  • Waverly Advisors's Repligen position peaked at $5.05M in Q4 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Waverly Advisors's 13F filing for Q1 2026, filed 15 May 2026.